Monthly Archives: April 2017
Presentation of the Julius M. Friedenwald Medal to Anil K. Rustgi
Established in 1941, the Julius M. Friedenwald Medal honors an individual who has contributed significantly to the American Gastroenterological Association (AGA) and has made lifelong contributions to the field of gastroenterology. This is the highest … Continue reading
The Relative Contributions of the Gut Microbiome, Host Genetics, and Environment to Cytokine Responses to Microbial Stimulation
Li Y, Oosting M, Smeekens SP, et al. A functional genomics approach to understand variation in cytokine production in humans. Cell 2016;167:1099-1110.e14. Continue reading
Household Dust, Innate Immunity, and the Amish: Lessons for Eosinophilic Esophagitis?
Stein MM, Hrusch CL, Gozdz J, et al. Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children. N Engl J Med 2016; 375:411-421. Continue reading
Information for Authors and Readers
Gastroenterology is the premiere journal in the field of gastrointestinal disease and is led by an internationally renowned board of editors. As the official journal of the AGA Institute, Gastroenterology delivers up-to-date and authoritative coverag… Continue reading
How to Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities
For gastroenterology (GI) fellows, exposure to inflammatory bowel disease (IBD) during training will vary widely based on institutional expertise, educational standards, personal interest, and resources to attend regional and national meetings. This ex… Continue reading
Surveillance for One or Two Small Adenomas: Low Risk Is Really Low Risk
The optimal timing for postpolypectomy surveillance for low-risk adenomas, defined as 1-2 small tubular adenomas, has remained a challenge for clinicians and guideline developers over past 4 decades. From the 1970s to the 1990s, it was common practice for clinicians to recommend annual surveillance for even a small adenoma (ie, <10 mm), because of the perceived knowledge that all adenomas were premalignant.1 In 1993, the National Polyp Study helped to provide much needed evidence for the timing of postpolypectomy surveillance by showing there was no difference in the risk of finding an advanced adenoma at 1 and 3 years after the baseline colonoscopy versus 3 years alone. Continue reading
Predictors of the Clinical Course of Primary Sclerosing Cholangitis
The clinical course of primary sclerosing cholangitis (PSC) is highly variable. Some patients are asymptomatic for years, whereas others develop end-stage liver disease or cholangiocarcinoma (CCA) shortly after diagnosis.1–4 Previous studies have rep… Continue reading